| UniProt ID | ARI2_HUMAN | |
|---|---|---|
| UniProt AC | O95376 | |
| Protein Name | E3 ubiquitin-protein ligase ARIH2 | |
| Gene Name | ARIH2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 493 | |
| Subcellular Localization | Nucleus . Cytoplasm . | |
| Protein Description | E3 ubiquitin-protein ligase, which catalyzes ubiquitination of target proteins together with ubiquitin-conjugating enzyme E2 UBE2L3. [PubMed: 16118314] | |
| Protein Sequence | MSVDMNSQGSDSNEEDYDPNCEEEEEEEEDDPGDIEDYYVGVASDVEQQGADAFDPEEYQFTCLTYKESEGALNEHMTSLASVLKVSHSVAKLILVNFHWQVSEILDRYKSNSAQLLVEARVQPNPSKHVPTSHPPHHCAVCMQFVRKENLLSLACQHQFCRSCWEQHCSVLVKDGVGVGVSCMAQDCPLRTPEDFVFPLLPNEELREKYRRYLFRDYVESHYQLQLCPGADCPMVIRVQEPRARRVQCNRCNEVFCFKCRQMYHAPTDCATIRKWLTKCADDSETANYISAHTKDCPKCNICIEKNGGCNHMQCSKCKHDFCWMCLGDWKTHGSEYYECSRYKENPDIVNQSQQAQAREALKKYLFYFERWENHNKSLQLEAQTYQRIHEKIQERVMNNLGTWIDWQYLQNAAKLLAKCRYTLQYTYPYAYYMESGPRKKLFEYQQAQLEAEIENLSWKVERADSYDRGDLENQMHIAEQRRRTLLKDFHDT | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 44 | Phosphorylation | DYYVGVASDVEQQGA HHEEEEECCHHHCCC | 39.52 | 26074081 | |
| 85 | Ubiquitination | TSLASVLKVSHSVAK HHHHHHHHHHHHHHH | 39.26 | - | |
| 113 | Phosphorylation | LDRYKSNSAQLLVEA HHHHHCCCCEEEEEE | 25.20 | 27251275 | |
| 259 | Ubiquitination | CNEVFCFKCRQMYHA CCCEEEEECCEECCC | 29.68 | - | |
| 279 | Ubiquitination | TIRKWLTKCADDSET HHHHHHHHHCCCHHH | 25.84 | - | |
| 289 | Phosphorylation | DDSETANYISAHTKD CCHHHHHHHHHCCCC | 8.19 | 27642862 | |
| 295 | Ubiquitination | NYISAHTKDCPKCNI HHHHHCCCCCCCCCE | 47.68 | - | |
| 299 | Ubiquitination | AHTKDCPKCNICIEK HCCCCCCCCCEEEEE | 46.36 | - | |
| 335 | Phosphorylation | GDWKTHGSEYYECSR CCCCCCCCCCCCCCC | 18.15 | 28152594 | |
| 337 | Phosphorylation | WKTHGSEYYECSRYK CCCCCCCCCCCCCCC | 13.27 | 28152594 | |
| 338 | Phosphorylation | KTHGSEYYECSRYKE CCCCCCCCCCCCCCC | 13.35 | 28152594 | |
| 341 | Phosphorylation | GSEYYECSRYKENPD CCCCCCCCCCCCCCC | 27.06 | 28152594 | |
| 344 | Ubiquitination | YYECSRYKENPDIVN CCCCCCCCCCCCCCC | 50.32 | 21906983 | |
| 353 | Phosphorylation | NPDIVNQSQQAQARE CCCCCCHHHHHHHHH | 21.03 | 17525332 | |
| 364 | Ubiquitination | QAREALKKYLFYFER HHHHHHHHHHHHHHH | 48.30 | 21906983 | |
| 377 | Ubiquitination | ERWENHNKSLQLEAQ HHHHHCCHHHHHHHH | 45.02 | 21906983 | |
| 392 | Ubiquitination | TYQRIHEKIQERVMN HHHHHHHHHHHHHHH | 35.21 | - | |
| 419 | Ubiquitination | NAAKLLAKCRYTLQY HHHHHHHHHCCEEEE | 21.15 | - | |
| 422 | Phosphorylation | KLLAKCRYTLQYTYP HHHHHHCCEEEECCC | 22.67 | 24043423 | |
| 423 | Phosphorylation | LLAKCRYTLQYTYPY HHHHHCCEEEECCCC | 6.50 | 24043423 | |
| 426 | Phosphorylation | KCRYTLQYTYPYAYY HHCCEEEECCCCEEE | 16.02 | 24043423 | |
| 427 | Phosphorylation | CRYTLQYTYPYAYYM HCCEEEECCCCEEEE | 12.69 | 24043423 | |
| 428 | Phosphorylation | RYTLQYTYPYAYYME CCEEEECCCCEEEEC | 6.85 | 24043423 | |
| 430 | Phosphorylation | TLQYTYPYAYYMESG EEEECCCCEEEECCC | 9.23 | 24043423 | |
| 432 | Phosphorylation | QYTYPYAYYMESGPR EECCCCEEEECCCCC | 9.48 | 24043423 | |
| 433 | Phosphorylation | YTYPYAYYMESGPRK ECCCCEEEECCCCCH | 6.04 | 24043423 | |
| 436 | Phosphorylation | PYAYYMESGPRKKLF CCEEEECCCCCHHHH | 37.25 | 24043423 | |
| 441 | Ubiquitination | MESGPRKKLFEYQQA ECCCCCHHHHHHHHH | 60.74 | 21890473 | |
| 460 | Ubiquitination | EIENLSWKVERADSY HHHHHCEEEEECCCC | 30.73 | 21906983 | |
| 466 | Phosphorylation | WKVERADSYDRGDLE EEEEECCCCCCCCHH | 28.13 | 20873877 | |
| 467 | Phosphorylation | KVERADSYDRGDLEN EEEECCCCCCCCHHH | 15.37 | 20873877 | |
| 488 | Ubiquitination | QRRRTLLKDFHDT-- HHHHHHHHHHCCC-- | 62.55 | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ARI2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ARI2_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-353, AND MASSSPECTROMETRY. | |